S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
1970’s computer coder issues shocking A.I. warning (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
[Urgent!] Generational Wealth Gameplan (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
Options trading has suddenly become more reliable. (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
1970’s computer coder issues shocking A.I. warning (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
[Urgent!] Generational Wealth Gameplan (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
Options trading has suddenly become more reliable. (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
1970’s computer coder issues shocking A.I. warning (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
[Urgent!] Generational Wealth Gameplan (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
Options trading has suddenly become more reliable. (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
1970’s computer coder issues shocking A.I. warning (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
[Urgent!] Generational Wealth Gameplan (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
Options trading has suddenly become more reliable. (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
NASDAQ:SXTC

China SXT Pharmaceuticals (SXTC) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free SXTC Stock Alerts
$0.99
-0.19 (-16.10%)
(As of 04/18/2024 ET)
Compare
Today's Range
$0.94
▼
$1.20
50-Day Range
$0.99
▼
$2.21
52-Week Range
$0.94
▼
$9.38
Volume
1.54 million shs
Average Volume
1.07 million shs
Market Capitalization
$455,400.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media
SXTC stock logo

About China SXT Pharmaceuticals Stock (NASDAQ:SXTC)

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.

SXTC Stock Price History

SXTC Stock News Headlines

April 16, 2024 | msn.com
JAGX, BSGM and SXTC among mid-day movers
February 23, 2024 | wsj.com
China SXT Pharmaceuticals Inc.
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
February 23, 2024 | benzinga.com
China SXT Pharmaceuticals Stock (NASDAQ:SXTC) Insider Trades
February 17, 2024 | finance.yahoo.com
China SXT Pharmaceuticals, Inc. (SXTC)
January 2, 2024 | markets.businessinsider.com
Dow Down 100 Points; US Manufacturing PMI Falls In December
December 31, 2023 | nasdaq.com
China SXT Pharma Continues To Spike
December 20, 2023 | morningstar.com
China SXT Pharmaceuticals Inc Ordinary Shares SXTC
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
October 26, 2023 | finance.yahoo.com
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule
October 26, 2023 | finance.yahoo.com
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule
October 4, 2023 | finanznachrichten.de
China SXT Pharmaceuticals, Inc.: China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split
October 4, 2023 | markets.businessinsider.com
China SXT Pharma Ordinary Shares To Begin Trading On Split-Adjusted Basis On Oct. 5
October 4, 2023 | finance.yahoo.com
China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split
September 7, 2023 | investorplace.com
Why Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today?
August 25, 2023 | seekingalpha.com
SXTC China SXT Pharmaceuticals, Inc.
August 21, 2023 | markets.businessinsider.com
Why Is China SXT Pharmaceuticals (SXTC) Stock Up 110% Today?
August 2, 2023 | finance.yahoo.com
China SXT Pharmaceuticals Full Year 2023 Earnings: US$0.89 loss per share (vs US$5.52 loss in FY 2022)
May 10, 2023 | finance.yahoo.com
China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule
March 29, 2023 | finance.yahoo.com
Insiders who placed huge bets on China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) earlier this year would be disappointed with the 12% drop
January 10, 2023 | reuters.com
China says talks to include Paxlovid in its insurance drug list fail
January 5, 2023 | benzinga.com
China SXT Pharmaceuticals Stock (NASDAQ:SXTC), Quotes and News Summary
May 18, 2022 | seekingalpha.com
China SXT Pharmaceuticals announces 1-for-20 reverse stock split
March 29, 2022 | investorplace.com
Why Is China SXT Pharmaceuticals (SXTC) Stock Up Today?
March 29, 2022 | seekingalpha.com
China SXT Pharmaceuticals climbs on heavy volume
March 15, 2022 | seekingalpha.com
China SXT Pharmaceuticals to raise $2.8M in convertible promissory note offering
March 14, 2022 | benzinga.com
China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million
See More Headlines
Receive SXTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China SXT Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/18/2024
Next Earnings (Estimated)
7/29/2024
Fiscal Year End
3/31/2025
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SXTC
CUSIP
N/A
CIK
1723980
Web
www.sxtchina.com
Phone
8652386299087
Fax
N/A
Employees
78
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
1.47
Quick Ratio
1.41

Sales & Book Value

Annual Sales
$1.97 million
Price / Sales
0.23
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$32.12 per share
Price / Book
0.03

Miscellaneous

Outstanding Shares
460,000
Free Float
439,000
Market Cap
$449,880.00
Optionable
Not Optionable
Beta
1.00
10 Best Stocks to Own in 2024 Cover
10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Feng Zhou (Age 32)
    Chairman of the Board & CEO
    Comp: $50k
  • Mr. Xiaodong Pan (Age 46)
    Chief Financial Officer
    Comp: $50k
  • Mr. Jun Zheng (Age 46)
    Executive Director

Key Competitors

View All Competitors

SXTC Stock Analysis - Frequently Asked Questions

How have SXTC shares performed in 2024?

China SXT Pharmaceuticals' stock was trading at $3.97 at the beginning of the year. Since then, SXTC stock has decreased by 75.1% and is now trading at $0.99.
View the best growth stocks for 2024 here.

Are investors shorting China SXT Pharmaceuticals?

China SXT Pharmaceuticals saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 26,200 shares, an increase of 376.4% from the March 15th total of 5,500 shares. Based on an average trading volume of 546,600 shares, the days-to-cover ratio is currently 0.0 days. Approximately 4.8% of the company's stock are short sold.
View China SXT Pharmaceuticals' Short Interest.

When is China SXT Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, July 29th 2024.
View our SXTC earnings forecast.

When did China SXT Pharmaceuticals' stock split?

China SXT Pharmaceuticals's stock reverse split on Thursday, October 5th 2023. The 1-25 reverse split was announced on Wednesday, October 4th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

What other stocks do shareholders of China SXT Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China SXT Pharmaceuticals investors own include iBio (IBIO), Remark (MARK), Aytu BioPharma (AYTU), BIMI (BIMI), My Size (MYSZ), Nabriva Therapeutics (NBRV), Sintx Technologies (SINT) and Sorrento Therapeutics (SRNE).

How do I buy shares of China SXT Pharmaceuticals?

Shares of SXTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SXTC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
Biden’s $374B Giveaway Into This Sector
DTI
Biden replacement revealed?
Paradigm Press
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The Next Nvidia?
InvestorPlace
How Biden has already won 2024
Porter & Company
Options trading has suddenly become more reliable.
Eagle Publishing
1970’s computer coder issues shocking A.I. warning
TradeSmith